NAS-SGAN: A Semi-Supervised Generative Adversarial Network Model for Atypia Scoring of Breast Cancer Histopathological Images

IEEE J Biomed Health Inform. 2022 May;26(5):2276-2287. doi: 10.1109/JBHI.2021.3131103. Epub 2022 May 5.

Abstract

Nuclear atypia scoring (NAS), forms a significant factor in determining individualized treatment plans and also for the prognosis of the disease. Automation of cancer grading using quantitative image-based analysis of histopathological images can circumvent the shortcomings of the prevailing manual grading and can assist the pathologists in cancer diagnosis. However, developing such a robust classifier model require sufficient amount of annotated data, while the labeled histopathological images are scarce and expensive to procure as annotation forms a time-consuming and laborious task. Hence, a semi-supervised learning framework combined with the deep neural network based generative adversarial training, that can improve the performance of the classification model with limited annotated data, is proposed in this paper. The proposed NAS-SGAN model consists of discriminator and generator models that are trained in an adversarial manner using both labeled and unlabeled samples. The discriminator model is designed as an unsupervised model stacked over the supervised model sharing the model parameters and learns the data distribution by extracting the discriminative features. The generator model is trained over a stable feature matching objective function following a composite GAN architecture, and its for the first time the semi-supervised GAN model is explored for the grading of breast cancer. Experimental analysis shows that the proposed model could better discriminate different cancer grades thereby improving the robustness and accuracy of the system, even with limited amount of labeled samples.

MeSH terms

  • Breast Neoplasms* / diagnostic imaging
  • Female
  • Humans
  • Neural Networks, Computer
  • Plant Extracts
  • Prognosis
  • Supervised Machine Learning

Substances

  • Plant Extracts
  • nas